Due to the sophistication of red cell compatibility testing, the majority of transfusion reactions are non-haemolytic in origin. This paper reviews the clinical presentation of these reactions, emphasising that blood transfusion reaction must always be considered in the differential diagnosis when a patient develops unexpected complications during his hospital stay. Fever, allergic reactions, respiratory distress, hypotension and jaundice may all be manifestations of a transfusion reaction.
RudowskiW.J.Complications associated with blood transfusion. Prog Surg1971; 9: 78.
2.
BakerR.J., MoinichenS.L., NyhusL.M.Transfusion reaction. A reappraisal of surgical incidence and significance. Ann Surg1969; 169: 684.
3.
MollisonP.L.Blood transfusion in clinical medicine.Blackwell Scientific Publications, Oxford1979.
4.
KayA.B.Some complications associated with the administration of blood and blood products. Clin Haematol1976; 5: 165.
5.
BrittinghamT.E., ChaplinHJr.. Febrile transfusion reactions caused by sensitivity to donor leucocytes and platelets. JAMA1957; 165: 819.
6.
PayneR., RolfsM.R.Further observations on leukoagglutinin transfusion reactions with special reference to leukoagglutinin transfusion reactions in women. Amer J Med1960; 29: 449.
7.
PayneR.The association of febrile transfusion reactions with leukoagglutinins. Vox Sang (Basel)1957; 2: 233.
8.
McCulloughJ., BurkeM.E., WoodN., CarterS.J., WeiblenB.J., YunisE.J.Microcapillary agglutination for the detection of leucocyte antibodies: evaluation of the method and clinical significance in transfusion reactions. Transfusion1974; 14: 425.
9.
MollisonP.L.Some clinical consequences of red cell incompatibility. J R Coll Physicians Lond1979; 13: 15.
10.
PerkinsH.A., PayneR., FergusonJ., WoodM.Nonhaemolytic febrile transfusion reactions. Quantitative effects of blood components with emphasis on isoantigenic incompatibility of leucocytes. Vox Sang (Basel)1966; 11: 578.
11.
PinedaA.A., BrzicaS.M., TaswellH.F.Hemolytic transfusion reaction. Recent experience in a large blood bank. Mayo Clin Proc1978; 53: 378.
12.
WolfC.F.W., CanaleV.C.Fatal pulmonary hypersensitivity reaction to HL-A incompatible blood transfusion: Report of a case. Transfusion1974; 14: 509.
13.
ThompsonJ.S., SeversonC.D., ParmelyM.J., MarmorsteinB.L., SimmonsA.Pulmonary ‘hypersensitivity’ reactions induced by transfusion of non-HL-A leukoagglutinins. New Engl J Med1971; 284: 1120.
14.
ThulstrupH.The influence of leucocyte and thrombocyte incompatibility on nonhaemolytic transfusion reactions. I. A retrospective study. Vox Sang (Basel)1971; 21: 233.
PepperD.S.Frozen red cells. Clin Haematol1976; 5: 53.
17.
StephenC.R., MartinR.C., Bourgeois-GavardinM.Antihistaminic drugs in treatment of nonhemolytic transfusion reactions. JAMA1955; 158: 525.
18.
VyasG.N., PerkinsH.A., YangY.M., BasantaniG.K.Healthy blood donors with selective absence of immunoglobulin A: prevention of anaphylactic transfusion reactions caused by antibodies to IgA. J Lab clin Med1975; 85: 838.
19.
KoistinenJ., LeikolaJ.Weak anti-IgA antibodies with limited specificity and nonhaemolytic transfusion reactions. Vox Sang (Basel)1977; 32: 77.
20.
RoparsC., CalderaL.H., GriscelliC., HombergJ.C., SalmonC.Anti-immunoglobulin antibodies in immunodeficiencies: their influence on intolerance reactions to y-globulin administration. Vox Sang (Basel)1974; 27: 294.
21.
VyasG.N., PerkinsH.A.Anti-IgA in blood donors (letter). Transfusion1976; 16: 289.
22.
BraudeA.I., SandfordJ.P., BartlettJ.E., MalleryO.T.Jr.. Effects and clinical significance of bacterial contaminants in transfused blood. J Lab Clin Med1952; 39: 902.
KeownP.A., DescampsB.Improved renal allograft survival after blood transfusion: a non-specific, erythrocyte-mediated immunoregulatory process. Lancet1979; 1: 20.
25.
Van EsA.A., MarquetR.L., van RoodJ.J., KalffM.W., BalnerH.Blood transfusions induce prolonged kidney allograft survival in rhesus monkeys. Lancet1977; 1: 506.
26.
PinedaA.A., TaswellH.F., BrzicaS.M.Delayed hemolytic transfusion reaction. An immunologic hazard of blood transfusion. Transfusion1978; 18: 1.
27.
ConradM.E.Current status of post-transfusion hepatitis. Am J Hematol1976; 1: 357.
28.
ConradM.E., KnodellR.G., BradleyE.L.Jr., FlanneryE.P., GinsbergA.L.Risk factors in transmission of non-A, non-B post transfusion hepatitis. The role of hepatitis B antibody in donor blood. Transfusion1977; 17: 579.
29.
AlterH.J., PurcellR.H., HollandP.V., FeinstoneS.M., MorrowA.G., MoritsuguY.Clinical and serological analysis of transfusion-associated hepatitis. Lancet1975; 2: 838.
30.
BlumbergB.S.Non-A, non-B hepatitis. Ann Intern Med1977; 87: 111.
31.
TaborE., AprilM., SeeffL.B., GeretzR.J.Acute non-A, non-B hepatitis. Prolonged presence of infectious agent in blood. Gastroenterology1979; 76: 680.
32.
KrugmanS., OverbyL.R., MushahiwarI.K., LingC.M., FrösnerG.G., DeinhardtF.Viral hepatitis, type B. Studies on natural history and prevention reexamined. New Engl J Med1979; 300: 101.
33.
NelsonM., CookeB.The incidence of Australia antigen in blood donors and in certain high-risk patient populations. Med J Aust1971; 1: 950.
34.
GustI.D.Recent developments in hepatitis A. Pathology1978; 10: 299.
35.
La MontJ.T., IsselbacherK.J.Postoperative jaundice. New Engl J Med1973; 288: 305.
